113 related articles for article (PubMed ID: 11361573)
1. Vaccines repress HIV in children.
AIDS Patient Care STDS; 1996 Dec; 10(6):381. PubMed ID: 11361573
[No Abstract] [Full Text] [Related]
2. AIDS vaccine trial disappointing.
Science; 1996 Apr; 272(5260):341. PubMed ID: 8602519
[No Abstract] [Full Text] [Related]
3. Vaccines for control of HIV infections.
Sharma KB
J Indian Med Assoc; 1994 Jan; 92(1):27-8. PubMed ID: 8207277
[No Abstract] [Full Text] [Related]
4. A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunization.
Coulaud IP; Gougeon ML; Gomard E; Descamps D; Lebon P; Aboulker JP; Bizzini B; Zagury D
AIDS; 1997 Jun; 11(7):937-8. PubMed ID: 9189226
[No Abstract] [Full Text] [Related]
5. Remune trials recruiting.
PI Perspect; 1996 Sep; (No 19):17. PubMed ID: 11363901
[TBL] [Abstract][Full Text] [Related]
6. Progress in development and testing of novel recombinant vaccine platforms for HIV.
Weiner DB
Springer Semin Immunopathol; 2006 Nov; 28(3):195-6. PubMed ID: 17043866
[No Abstract] [Full Text] [Related]
7. Therapeutic vaccines for chronic infections.
Autran B; Carcelain G; Combadiere B; Debre P
Science; 2004 Jul; 305(5681):205-8. PubMed ID: 15247470
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic HIV vaccine from Spain.
Burton A
Lancet Infect Dis; 2001 Dec; 1(5):291. PubMed ID: 11871794
[No Abstract] [Full Text] [Related]
9. Update on HIV vaccines.
Meldorf M; Corey L
STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929
[TBL] [Abstract][Full Text] [Related]
10. The design and testing of HIV prophylactic vaccines.
Ada G
AIDS Res Hum Retroviruses; 1992 May; 8(5):758-63. PubMed ID: 1515227
[No Abstract] [Full Text] [Related]
11. The HIV/AIDS pandemic--virology update.
van Rensburg EJ
SADJ; 2002 Dec; 57(11):438, 440. PubMed ID: 12674858
[No Abstract] [Full Text] [Related]
12. AIDS vaccine: efficacy, safety and ethics.
Veljkovic V; Veljkovic N; Glisic S; Ho MW
Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
[TBL] [Abstract][Full Text] [Related]
13. Improving immune function and controlling viral replication in HIV-1-infected patients with immune-based therapies.
Angel JB
AIDS Read; 2001 Apr; 11(4):209-21. PubMed ID: 11392678
[TBL] [Abstract][Full Text] [Related]
14. Web alert. Molecular, viral and cell-based vaccines for disease prevention and therapy.
Stephens AC
Curr Opin Mol Ther; 2004 Feb; 6(1):6-7. PubMed ID: 15011774
[No Abstract] [Full Text] [Related]
15. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
Bhardwaj N; Walker BD
Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
[No Abstract] [Full Text] [Related]
16. Intrigue grows around Redfield report.
Science; 1993 Jul; 261(5119):283. PubMed ID: 8332893
[No Abstract] [Full Text] [Related]
17. Outwitting HIV: Minnesota researchers take on a clever virus.
Bell H
Minn Med; 2009 Oct; 92(10):22-6. PubMed ID: 19916268
[No Abstract] [Full Text] [Related]
18. Immunologic approaches to the therapy of HIV-1 infection.
Sneller MC; Lane HC
Ann N Y Acad Sci; 1993 Jun; 685():687-96. PubMed ID: 8363275
[No Abstract] [Full Text] [Related]
19. Does the HIV-1deltakURNe vaccine strain hold the key to curbing HIV infection? An interview with Ronald Desrosiers, PhD.
Desrosiers R
J Int Assoc Physicians AIDS Care; 1998 Mar; 4(3):45-6. PubMed ID: 11365180
[TBL] [Abstract][Full Text] [Related]
20. Keeping hope alive: HIV vaccines & the community.
Montecalvo M
Body Posit; 2004; 17(4):15-6. PubMed ID: 15929209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
